"Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness"

NCT05360784 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Redness

Interventions

DRUG: Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
DRUG: Lumify® (brimonidine tartrate ophthalmic solution 0.025%)

Sponsor

Bausch & Lomb Incorporated